[Autograft and multiple myeloma: experience of the Intergroupe Français du Myélome]
Related Experiment Video
Updated: Oct 4, 2026

10:04
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
1Service d'hématologie, CHU Purpan, place du Docteur-Baylac, 31059 Toulouse.
Bulletin Du Cancer
|October 18, 2001
Abstract:
This article summarizes the different clinical results of the IFM trials: high dose therapy supported with autologous stem cells improves survival, melphalan 200 mg/m2 is the best preparative regimen, unpurged peripheral blood stem cells are the recommended source of stem-cells to support high dose therapy, tandem transplants significantly improve survival. However, despite these encouraging results, long term survival needs inovative strategies evaluated with the current IFM 99 protocol.

